原发性脾脏肿瘤43例临床诊治分析  

Diagnosis and treatment of primary splenic tumor： an analysis of 43 cases

作　　者：章琎[1] 方国恩[1] 毕建威[1] 

机构地区：[1]第二军医大学附属长海医院普外科,上海200433

出　　处：《中华肝胆外科杂志》2009年第7期509-511,共3页Chinese Journal of Hepatobiliary Surgery

摘　　要：目的总结原发性脾脏肿瘤的诊断和治疗经验。方法回顾性分析1990年1月至2003年1月收治的43例原发性脾脏肿瘤的临床病例资料。结果B超检出率为95．3％（41／43），CT检出率为96．6％（28／29）。43例原发性脾脏肿瘤中良性肿瘤28例，恶性肿瘤15例，随访2个月至15年（中位6．8年），良性肿瘤5年生存率100％，恶性肿瘤1、3、5年生存率分别为80％、53．3％和26．7％。结论B超、CT等影像学检查是原发性脾脏肿瘤的主要诊断方法，早期诊断、根治性手术和综合治疗是改善原发性脾脏恶性肿瘤预后的关键。Objective To summarize the experience in diagnosis and treatment of primary splenic tumor. Methods The clinical data of 43 cases of primary splenic tumor patients treated in our hospital between January 1990 to January 2003 were retrospectively analyzed. Results The detectable rate of B-US was 95.3% and that of CT was 96.6%. All the 43 patients included 28 with benign tumors and 15 with malignant ones. The median follow-up period was 6.8 years（2 months 15 years）. The 5 year overall survival of benign tumor was 100% and The 1-, 3-and 5-year overall survival rates of malignant tumor were 80%, 53.3% and 26.7%, respectively. Conclusion The image methods such as B-US and CT are the main diagnostic methods for primary splenic tumor. Early diagnosis,radical operation and combined therapy are important for improving the prognosis of the tumor.

关 键 词：脾肿瘤 诊断 治疗 脾切除术 

分 类 号：R686[医药卫生—骨科学]